Lv4
728 积分 2024-02-16 加入
743-P: Efficacy and Safety of VCT220 in Chinese Adults with Overweight or Obesity
2天前
已完结
Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2
19天前
已完结
China type 2 diabetes treatment status survey of treatment pattern of oral drugs users
25天前
已完结
Phase I study of the oral GLP ‐1 receptor agonist DA ‐ 302168S : Safety, pharmacokinetics, and pharmacodynamics in healthy and overweight/obese adults
27天前
已完结
New drug therapies for hypertension
1个月前
已完结
A novel peptide design aids in the expression and its simplified process of manufacturing of Insulin Glargine in Pichia pastoris
1个月前
已完结
New and efficient purification process for recombinant human insulin produced in Escherichia coli
1个月前
已完结
HTD1801 in Combination with Metformin for Type 2 Diabetes
1个月前
已完结
Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone
1个月前
已完结
Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
